Watch for the New Oral GLP-1 Agonist Orforglipron
May 2026
New Rx orforglipron (Foundayo) is the second ORAL GLP-1 receptor agonist approved for adults with overweight or obesity.
It’s another DAILY option...like oral semaglutide (Wegovy).
But orforglipron can be taken with or without food. Oral semaglutide must be taken with a max of 4 oz of water at least 30 minutes before the first food, other beverage, or oral meds of the day.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive